Interstitial And Fibrotic Lung Disease
-
A 62-year-old man presents to your clinic for follow-up evaluation of shortness of breath and dry cough. His breathlessness on exertion started insidiously 6 months ago. Review of his evaluation reveals pulmonary function tests consistent with restriction and severely decreased diffusing capacity of the lung for carbon monoxide (DLCO). Highresolution computed tomography (HRCT) demonstrates bibasilar reticular abnormalities without ground-glass opacities or consolidation. A transbronchial lung biopsy was nondiagnostic. All serologies for connective tissue disease have been negative, and on repeat history today, the patient denies any past exposure to heavy metals, chemical toxins, molds, dusts, or asbestosis. On examination today, you note a resting O2 saturation of 88% on room air and bibasilar inspiratory crackles. There is no jugular venous distention, s3, or peripheral edema. Which of the following is the most likely diagnosis for this patient?
-
Acute interstitial pneumonitis
-
Cryptogenic organizing pneumonia (COP)
-
Idiopathic pulmonary fibrosis (IPF)
-
Mycoplasma pneumonia
-
Congestive heart failure
-
About This Quiz
Click on the link below and read the article prior to completing the quiz. https://rms1. Newinnov. Com/Administration/GetFile. Aspx? File=87470854E6AD 28D1AD2BF91FC8919673
(129).jpg "Interstitial And Fibrotic Lung Disease - Quiz")
Quiz Preview
- 2.
A 61-year-old man with hypertension and hyperlipidemia returns to your clinic for follow-up on cough and shortness of breath. Over the past several months, he has had several bouts of "pneumonia," which have not responded to moxifloxacin or amoxicillin outpatient therapy. His chest x-rays have demonstrated persistent alveolar opacities throughout the illness. After several courses of antibiotics and months of shortness of breath and productive cough, you referred the patient to a cardiothoracic surgeon for video-assisted thoracoscopic lung biopsy. Today you received a pathology report stating that the biopsy was consistent with cryptogenic organizing pneumonia (COP). What is the most appropriate next step for this patient?
-
Prescribe a 3-month course of doxycycline
-
Prescribe prednisone, 60 mg daily
-
Initiate mycophenolate mofetil
-
Observe the patient; follow up in 3 months
Correct Answer
A. Prescribe prednisone, 60 mg dailyExplanation
Unlike many of the idiopathic interstitial pneumonias, cryptogenic organizing pneumonia (COP) can often be treated effectively, at least initially. Corticosteroids are the mainstay of initial therapy, typically at moderate to high doses over several months to a year. No standardized consensus has been reached: some treat with once-daily doses of 1 mg/kg prednisone (60 mg/day) for 1 to 3 months, followed by 40 mg/day for 3 months and then tapering for a total duration of 1 year, whereas others have suggested shorter courses initially. Although shorter courses may be effective in certain individuals, relapses are common, often within 1 to 3 months of discontinuing or even tapering corticosteroids. Parenteral methylprednisoloneat doses of 500 to 1,000 mg/day ("pulse dosing") has been recommended for particularly rapidly progressing forms of COP, and cytotoxic therapy with cyclophosphamideand azathioprine has been used.Rate this question:
-
- 3.
A 49-year-old previously healthy man presented to the emergency room (ER) with 3 weeks of progressive shortness of breath. He has noticed headaches, myalgias, malaise, sore throat, and a productive cough. His dyspnea has progressed to the point that he is now markedly short of breath at rest. He denied any recent exposures or inhalation. On arrival to the ER, his O2 saturation was 82% on room air, and he was in marked respiratory distress. He was intubated and transferred to the intensive care unit. A chest x-ray on admission demonstrated bilateral pulmonary opacities. His arterial oxygen tension (PaO2) was 115 mm Hg on 100% fraction of inspired oxygen (FiO2). Right heart catheterization demonstrated a pulmonary capillary wedge pressure of 13 cm H2O. All cultures, including bronchoalveolar lavage fl uid, were negative for bacterial, fungal, or viral pathogens. Transbronchial biopsy revealed diffuse alveolar damage. A rapid fl u test was negative. Which of the following is the most likely diagnosis in this patient?
-
Acute interstitial pneumonia
-
Nonspecific interstitial pneumonia
-
Lupus pneumonitis
-
Miliary tuberculosis
-
Desquamative interstitial pneumonia
Correct Answer
A. Acute interstitial pneumoniaExplanation
The onset of AIP is typically abrupt, with several days of a fl ulike illness with headaches, myalgias, malaise, sore throat, and productive cough. Exertional dyspnea ensues, often becoming severe. Patients typically present within 3 weeks of the onset of their symptoms appearing quite ill. Fever is present in half of patients at presentation, but all investigations for infectious etiologies are, by defi nition, negative. Examination may show evidence of widespread consolidation or diffuse crackles. Digital clubbing is typically absent in AIP, and its presence might suggest a diagnosis of acute exacerbation of (undiagnosed) IPF. Pulmonary function testing, when done, shows a restrictive pattern with gas exchange impairments, which are often severe. Hypoxemia is present, and patients commonly require mechanical ventilation. By clinical criteria, patients meet the defi nition of ARDS, namely, an acute onset, a PaO2 to FIO2 ratio of less than 200, diffuse bilateral opacities on chest imaging, and a pulmonary arterial occlusion pressure of less than 18.Rate this question:
-
- 4.
A 68-year-old woman with known IPF presents to your offi ce for follow-up. She states that her lung breathing trouble seems to be about the same, but she has felt a little weaker lately. Today on examination, her O2 saturation is 93% on 2 L O2 by nasal cannula. Her lung examination again reveals coarse, Velcro-like inspiratory crackles at both bases. She does not have elevated jugular venous pressure or peripheral edema, but you do note clubbing. Her pulmonologist has recently been treating her lung disease with prednisone and azathioprine, but the patient is not sure if this is helping. You order an arterial blood gas, chest x-ray, pulmonary function testing, and a 6-minute walk test. Which of the following findings would be most predictive of further clinical deterioration of the patient's disease?
-
Decrease in forced vital capacity (FVC) by 12% from her previous study
-
Moderate increase in reticular opacities on chest x-ray
-
Carbon dioxide tension (PCO2) > 45 mm Hg on arterial blood gas
-
Decrease in distance walked in 6 minutes by 10 meters
Correct Answer
A. Decrease in forced vital capacity (FVC) by 12% from her previous studyExplanation
Ostensibly, similar patients may behave quite differently over time, and our ability to distinguish this on initial assessment is relatively poor. Several authors have investigated the predictive power of trends in clinical progression to predict mortality. A number of studies have now pointed to a change in FVC, often set at 10%, as being clinically predictive of further disease progression. Other measures of disease progression, such as measures of oxygenation (A-a gradient, DLCO, amount of desaturation on a 6-minute walk test) and a decrease in 6-minute walk distance, may have prognostic signifi cance. Of all of these, a change in FVC of 10% may be the most reliable end point.Rate this question:
-
- 5.
A 58-year-old male former smoker returns to your clinic for a follow-up appointment for IPF. On your initial evaluation, he reported several months of insidiously worsening shortness of breath and dry cough. He denied any significant previous exposures, and all serologies for connective tissue diseases were negative. HRCT demonstrated peripheral interstitial opacities with honeycombing and traction bronchiectasis. A surgical lung biopsy was consistent with usual interstitial pneumonia (UIP). For this patient, which of the following therapies has proven survival benefit?
-
Prednisone
-
Prednisone + cyclophosphamide
-
Methotrexate
-
Lung transplantation
-
Colchicine
Correct Answer
A. Lung transplantationExplanation
Unfortunately, there is no proven therapy for the treatment of IPF. In spite of these limitations, pulmonologists and internists continue to prescribe medications without proven benefi t in the hope that an individual patient might respond. Fortunately, more placebo-controlled trials are in progress or planned for the near future. Lung transplantation remains the only therapy for IPF with proven survival benefi t. Under the previous organ allocation system used in the United States for lung transplantation, time on the waiting list was paramount in a patient being offered a transplant. Under this system, the median time on the waiting list was roughly 2 years. As of May 2006, the allocation system was revised such that a complex, iterative formula comparing anticipated benefi t from transplantation with anticipated clinical course in the absence of transplantation now determines the priority of organ allocation. As a result, the waiting time for patients with IPF has decreased considerably.Rate this question:
-
Quiz Review Timeline (Updated): Mar 22, 2023 +
Our quizzes are rigorously reviewed, monitored and continuously updated by our expert board to maintain accuracy, relevance, and timeliness.
-
Current Version
-
Mar 22, 2023Quiz Edited by
ProProfs Editorial Team -
Dec 01, 2009Quiz Created by
Uscsom_im
Back to top